Avion Pharmaceuticals, LLC., Launches Prenate Mini
ATLANTA, July 24, 2012 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, announces the launch of Prenate Mini, the newest addition to the Prenate family of vitamins. Prenate Mini is unique in its size and nutritional value, using the next generation folate Quatefolic, DHA and essential vitamins and minerals all in one easy-to-swallow gel cap.
"Avion is excited to offer women Prenate Mini as an option for potentially improved tolerability, making nutrition an easy part of prenatal care for women during pregnancy," said Mike Sullivan, Vice President, Sales and Marketing, for Avion Pharmaceuticals. "Prenate Mini is the first of many innovative nutritional offerings that Avion will be offering women through our new Prenate Continuum of Care."
"We are extremely pleased about the launch of Prenate Mini as we continue to build upon our Prenate franchise, which will be launched by our national sales force," said Mark Pugh, Chief Executive Officer of Avion Pharmaceuticals. "This is the first of many new product offerings that Avion will bring to market in women's health, further establishing our company as the premier women's health specialty pharmaceutical company in the U.S."
About Avion Pharmaceuticals, LLC.
Avion Pharmaceuticals, LLC., is a Specialty Pharmaceutical company formed to develop and market a portfolio of innovative pharmaceutical products in the Women's Heath and Dermatology therapeutic areas. Avion Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs. For additional information about Avion Pharmaceuticals please contact the company at 678-325-5188.
SOURCE Avion Pharmaceuticals, LLC.